| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.042 | 0.3 |